Viewing Study NCT05621668


Ignite Creation Date: 2025-12-24 @ 5:39 PM
Ignite Modification Date: 2025-12-28 @ 12:43 AM
Study NCT ID: NCT05621668
Status: RECRUITING
Last Update Posted: 2025-10-17
First Post: 2022-11-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module